Imagine a future where science picks up where nature Ileaves off—where a groundbreaking treatment regenerates damaged nerves, restoring movement after spinal cord injuries and reversing vision loss from optic nerve damage. This isn’t science fiction; it’s the future that biotechnology and regenerative medicine are striving to create. Transformative breakthroughs emerge
TORONTO and HAIFA, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced that an independent study showed that exosomes produced by NurExone outperformed a recognized commercial industry standard in areas that strongly support key healing tasks including
TORONTO and HAIFA, Israel, July 25, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that the Falling Walls Foundation has named the Company a finalist in Falling Walls Venture 2025, a global platform that showcases the world’s
